The use of preexposure treatments for HIV prophylaxis.

HIV/AIDS : Research and Palliative Care
Adrian MajidBruce L Gilliam

Abstract

Infection with human immunodeficiency virus remains a global concern with a significant number of incident infections still reported worldwide. The use of prophylaxis prior to exposure to the virus to prevent infection has been a growing area of recent research. Results in nonhuman primates and clinical trials in high-risk patient populations using preexposure prophylaxis have shown promising results in terms of efficacy and safety, especially relating to oral preexposure prophylaxis. The potential use of oral antiretroviral agents traditionally used for human immunodeficiency virus treatment as prophylaxis raises interesting considerations, such as the best agents available for such a role, long-term safety in healthy individuals, and the potential development of resistance to these agents should infection occur. From a public health perspective, the cost-effectiveness of implementing this preventive strategy has not been fully defined at this point in time.

References

Apr 1, 1990·American Journal of Public Health·Z A Stein
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M TisdaleB A Larder
Jun 3, 1999·The Journal of Infectious Diseases·N BourneL R Stanberry
Oct 3, 2001·The Journal of Antimicrobial Chemotherapy·F S RousseauC van der Horst
Sep 27, 2003·The Journal of Infectious Diseases·Jeannette M WhitcombChristos J Petropoulos
Jan 15, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Shilpa M PatelCharles Bennett
May 3, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ume L AbbasJohn W Mellors
Jan 27, 2007·The Cochrane Database of Systematic Reviews·J VolminkP Brocklehurst
Apr 18, 2007·Annals of Internal Medicine·Myron S CohenLynn Paxton
Aug 2, 2008·The New England Journal of Medicine·Lut Van DammeUNKNOWN CS Study Group
Aug 5, 2008·JAMA : the Journal of the American Medical Association·H Irene HallUNKNOWN HIV Incidence Surveillance Group
Nov 11, 2008·The Lancet Infectious Diseases·Blayne Cutler, Jessica Justman
Jun 24, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Julie B DumondAngela D M Kashuba
Jul 10, 2009·The Journal of Infectious Diseases·Pedro M M MesquitaBetsy C Herold
Dec 10, 2009·Antimicrobial Agents and Chemotherapy·Caroline BarauAnne-Marie Taburet
Dec 17, 2009·Nature Reviews. Immunology·Andrew J McMichaelBarton F Haynes
Jan 9, 2010·AIDS Research and Human Retroviruses·Rowena Johnston, Chris Collins
Apr 8, 2010·Science Translational Medicine·J Gerardo García-LermaWalid Heneine
Jun 1, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sarit A GolubJeffrey T Parsons
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Virginie SupervieSally Blower
Sep 30, 2010·Pharmacotherapy·Frank Romanelli, Brian Murphy

❮ Previous
Next ❯

Citations

Feb 4, 2014·Enfermedades infecciosas y microbiología clínica·Rosa Polo RodríguezMaría Isabel González Tomé
Dec 3, 2014·Infectious Disease Clinics of North America·Amanda D CastelAlan E Greenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current HIV/AIDS Reports
Theodoros Kelesidis, Raphael J Landovitz
Clinical Investigation
Melanie R NicolAngela D M Kashuba
Journal of Medical Primatology
Thomas M Folks
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Christopher B HurtMyron S Cohen
© 2022 Meta ULC. All rights reserved